Category Archives: Cancer and neoplasms
Aug
The US Food and Drug Administration (FDA) has approved Reblozyl (luspatercept-aamt) to treat anemia in adults with very low- to intermediate-risk myelodysplastic syndromes (MDS) who may require regular red blood cell (RBC) transfusions and have not received prior treatment with erythropoiesis-stimulating agents (ESAs). The approval was based on interim results from the phase 3 COMMANDS […]
Cancer and neoplasms
Aberdeen University researchers receive funding boost into study for rare cancer
Aug
Researchers from the University of Aberdeen and Queen’s University Belfast have received a £280,000 boost from Blood Cancer UK. It will know form a study looking at DNA and samples from people with myeloproliferative neoplasms (MPN) to identify what may be responsible for causing the disease. MPN affects around four thousand people in the UK every […]
Scientists from Aberdeen have been given a boost in their research into a little-known blood cancer. The University of Aberdeen and Queen’s University Belfast have been awarded a £280,000 funding boost from Blood Cancer UK. Blood cancer is the fifth most common cause of cancer in the UK, and certain versions of it remain mysterious. […]
Cancer and neoplasms
CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma
Aug
Cell lines The cell lines used in this study, NKYS, YT and KAI3, were obtained from Dr. Wing C. Chan (City of Hope Medical Center, Los Angeles, USA). Dr. Norio Shimizu and Yu Zhang of Chiba University provided SNK6 cells. SNT16 cells were a gift from Guangzhou Bairui Biomedical Technology Company, Ltd. NKYS, YT, KAI3 […]
Aug
Researchers from the University of Aberdeen and Queen’s University Belfast have been awarded a £280,000 funding boost from Blood Cancer UK. It forms part of Blood Cancer UK’s latest funding for the illness, which is the fifth most common cause of cancer in the UK. Relatively little is known about the causes of a group […]
Cancer and neoplasms
Adult Myopia Market to Register Incremental Growth by 2032, Examines DelveInsight | Key Companies Working in the Market – ORA, LENZ Therapeutics, Glaukos, Santen, Cloudbreak, Nevakar, Eyenovia
Aug
New York, USA, Aug. 30, 2023 (GLOBE NEWSWIRE) — Adult Myopia Market to Register Incremental Growth by 2032, Examines DelveInsight | Key Companies Working in the Market – ORA, LENZ Therapeutics, Glaukos, Santen, Cloudbreak, Nevakar, Eyenovia The dynamics of the adult myopia market are anticipated to change in the coming years owing to the improvement […]
Aug
Colonoscopies using artificial intelligence increased detection of small polyps — but not colorectal neoplasms or advanced adenomas, which can be indicators of colorectal cancer — and resulted in higher rates of unnecessary polyp removal, according to a study published in Annals of Internal Medicine. The study, published Aug. 29, assessed the effectiveness of computer-aided detection […]
Aug
Yu-Jui Yvonne Wan Gene therapy that induces the body to create microRNA-22 (miR-22), a naturally occurring molecule, successfully treated mice with hepatocellular carcinoma, the most common form of liver cancer. The miR-22 treatment also reduced liver inflammation and produced better survival outcomes with no observable toxicity compared to the FDA-approved liver cancer treatment lenvatinib. Those […]
Aug
Beckwith–Wiedemann syndrome (BWS), the most prevalent epigenetic disorder, has a variety of clinical symptoms, including overgrowth, abdominal wall defects, and predisposition to embryonal tumors. The clinical symptoms of BWS range in severity and are commonly identified neonatally or in early childhood. Image Credit: Marko Poplasen/Shutterstock.com It is a human genomic imprinting disorder linked with changes in […]